Medical bioinformatics in melanoma

Area of Science:

• Genomic medicine
• Cancer biology
• Bioinformatics

Background:

• Next-generation sequencing (NGS) has revolutionized the understanding of melanoma.
• NGS technologies like whole-genome sequencing (WGS), whole-exome sequencing (WES), and RNA sequencing (RNA-seq) have redefined melanoma classification.
• These methods have uncovered genetic aberrations and tumor heterogeneity crucial for treatment resistance.

Purpose of the Study:

• To review recent advancements in melanoma research utilizing bioinformatics and sequencing technologies.
• To summarize findings from whole-genome studies on melanoma subtypes.
• To discuss single-cell RNA sequencing insights into tumor heterogeneity and personalized vaccine strategies.

Main Methods:

• Whole-genome sequencing (WGS) to analyze the genomic landscape of various melanoma subtypes.
• Single-cell RNA sequencing (scRNA-seq) to investigate intratumoral heterogeneity.
• Review of personalized vaccine approaches targeting tumor neoantigens.

Main Results:

• WGS revealed distinct genomic landscapes in acral and mucosal melanoma subtypes compared to cutaneous melanoma, characterized by low mutation burden and high structural variants.
• scRNA-seq identified significant intratumoral heterogeneity and rare drug-resistant cell populations.
• Tumor neoantigen vaccination emerged as a potential personalized therapy for melanoma patients.

Conclusions:

• Bioinformatics is fundamental to understanding melanoma biology, treatment resistance, and developing novel therapies.
• Distinct genomic profiles exist across melanoma subtypes, influencing therapeutic strategies.
• Personalized medicine, including neoantigen vaccination, holds promise for advancing melanoma treatment.